Reprotech
Fertility cryostorage infrastructure company providing long-term specimen storage, transport coordination, and lab software for IVF clinics and patients.
What They Do
Reprotech operates an offsite reproductive-tissue storage network for eggs, embryos, sperm, and other fertility specimens. Its platform combines long-term biorepository operations with workflow and matching software. Following its April 2026 merger announcement with TMRW Life Sciences, the company is positioning itself as a scaled national cryostorage and specimen-management backbone for fertility centers.
Competitive Position
Reprotech competes in fertility infrastructure rather than in front-end family-building benefits or clinic roll-ups. Together with TMRW Life Sciences, the combination suggests the category is consolidating around integrated storage, software, and logistics.
Funding Rounds
No funding rounds on record for this company.